AKUMS — Akums Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹148.05bn
- IN₹150.94bn
- IN₹41.78bn
Annual cashflow statement for Akums Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 1,723 | -1,932 | 1,503 | -453 |
Depreciation | ||||
Non-Cash Items | 752 | 5,367 | 449 | 4,305 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -1,862 | -4,064 | -1,314 | -129 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 1,311 | 319 | 1,766 | 4,979 |
Capital Expenditures | -828 | -2,576 | -3,288 | -3,114 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | -266 | 228 | 241 | -190 |
Sale of Fixed Assets | ||||
Sale/Maturity of Investment | ||||
Change in Net Investments | ||||
Purchase of Investments | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -1,094 | -2,348 | -3,047 | -3,304 |
Financing Cash Flow Items | -50.2 | -89.1 | -404 | -434 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -915 | 2,360 | 1,245 | -1,080 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -697 | 331 | -35.3 | 594 |